DrugPatentWatch Database Preview

ELLA Drug Profile

« Back to Dashboard

Which patents cover Ella, and what generic alternatives are available?

Ella is a drug marketed by Lab Hra Pharma and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has sixty-three patent family members in twenty-seven countries.

The generic ingredient in ELLA is ulipristal acetate. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ulipristal acetate profile page.

Summary for ELLA

International Patents:	63
US Patents:	5
Applicants:	1
NDAs:	1
Suppliers / Packagers:	3
Bulk Api Vendors:	53
Patent Applications:	47
Drug Prices:	Drug price information for ELLA
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ELLA
DailyMed Link:	ELLA at DailyMed

Pharmacology for ELLA

Drug Class	Progesterone Agonist/Antagonist
Mechanism of Action	Selective Progesterone Receptor Modulators

Synonyms for ELLA

(10S,11S,14R,15S,17R)-14-acetyl-17-[4-(dimethylamino)phenyl]-15-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1,6-dien-14-yl acetate

(10S,11S,14R,15S,17R)-14-acetyl-17-[4-(dimethylamino)phenyl]-15-methyl-5-oxotetracyclo[8.7.0.0?,?.0??,??]heptadeca-1,6-dien-14-yl acetate

(10S,11S,14R,15S,17R)-14-ACETYL-17-[4-(DIMETHYLAMINO)PHENYL]-15-METHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1,6-DIEN-14-YL ACETATE

(11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-yl acetate

(11beta)-17-(Acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione

(11beta)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione

(8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate

[(8S,11R,13S,14S,17R)-17-acetyl-11-(4-dimethylaminophenyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate

126784-99-4

17-Acetoxy-11-(4-N,N-dimethylaminophenyl)pregna-4,9-diene-3,20-dione

17beta-acetyl-11beta-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17alpha-yl acetate

19-Norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-, (11beta)-

19-Norpregna-4,9-diene-3,20-dione,17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-, (11b)-

3B1-000818

4oar

5-(Hydroxymethyl)-alpha,alpha,alpha,alpha-tetramethyl-1,3-benzenediacetonitrile

784A994

AB01566874_01

AC1L2Y8A

AKOS026750526

AMX10180

BDBM50375424

C30H37NO4

CBD 2914; VA 2914; (11b)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione

CDB 2914

CDB-2914

CHEBI:71025

CHEMBL260538

CS-1157

D09687

DTXSID30155294

EllaOne

EllaOne|||Esmya

EN300-220766

Esmya

FT-0675731

GTPL7460

Hrp-2000

HY-16508

J-005436

KB-81383

KS-00000Z24

MolPort-006-170-077

OOLLAFOLCSJHRE-ZHAKMVSLSA-N

PL009540

RTI 3021-012

SC-44720

SCHEMBL544957

U0102

Ulipristal (acetate)

Ulipristal acet

Ulipristal acetate

Ulipristal acetate (JAN/USAN)

Ulipristal acetate [USAN]

Ulipristal acetate, >=98% (HPLC)

Ulipristal acetate(CDB2914)

Ulipristal-Acetate

UNII-YF7V70N02B

VA2914

W-5201

X4788

YF7V70N02B

Z2216208644

ZINC3920657

US Patents and Regulatory Information for ELLA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lab Hra Pharma	ELLA	ulipristal acetate	TABLET;ORAL	022474-001	Aug 13, 2010	AB	RX	Yes	Yes
Lab Hra Pharma	ELLA	ulipristal acetate	TABLET;ORAL	022474-001	Aug 13, 2010	AB	RX	Yes	Yes			Y
Lab Hra Pharma	ELLA	ulipristal acetate	TABLET;ORAL	022474-001	Aug 13, 2010	AB	RX	Yes	Yes
Lab Hra Pharma	ELLA	ulipristal acetate	TABLET;ORAL	022474-001	Aug 13, 2010	AB	RX	Yes	Yes

Paragraph IV (Patent) Challenges for ELLA

Drugname	Dosage	Strength	RLD	Date
	Tablets	30 mg

International Patents for ELLA

Country	Document Number	Estimated Expiration
San Marino	T201600399
New Zealand	595790
Spain	2602134
Canada	2757496